Lundbeck acquires Alder in $2bn migraine treatment move
September 16, 2019Sales and Marketing Alder, Lundbeck, eptinezumab, migraine
Lundbeck is to buy Alder Biopharmaceuticals for $2 billion enhancing its leading portfolio of brain disease therapies through the acquisition …
Amgen’s Kyprolis + Darzalex combo shows progression-free survival benefit in multiple myeloma
September 16, 2019Research and Development, Sales and Marketing Amgen, Kyrpolis, darzalex, multiple myeloma, pharma
Amgen has revealed new Phase 3 data for the combination of Kyprolis (carfilzomib) and Darzalex (daratumumab) in addition to the …
Novartis announce robust Phase 3 trials for ofatumumab in MS
September 16, 2019Research and Development, Sales and Marketing Aubagio, Novartis, multiple sclerosis
Novartis’ multiple sclerosis candidate has demonstrated strong results in its Phase 3 ASCLEPIOS trials meeting primary endpoints and slashing the …
Multi-study data confirms Ocrevus’ long-term efficacy in reducing disability progression in multiple sclerosis
September 13, 2019Medical Communications, Research and Development ECTRIMS, Ocrevus, Roche, multiple sclerosis, pharma
Roche has taken the opportunity at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Stockholm …
Top Ten most popular articles on Pharmafile.com this week
September 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
It’s Friday again and time for another rundown of the top most popular articles on Pharmafile.com this week. This past …
UKRI Chief Executive Sir Mark Walport to step down in 2020
September 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma
Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …
General Pharmaceutical Council appoints Laura Fraser as director for Scotland
September 12, 2019The General Pharmaceutical Council has appointed Laura Fraser, former clinical fellow for the Scottish Chief Pharmaceutical Officer as the new …
Roche’s satralizumab succeeds in second positive study in rare CNS disease
September 12, 2019Research and Development NMOSD, Roche, satralizumab
In a second pivotal Phase 3 study of Roche’s satralizumab, the drug showed itself to significantly reduce relapse risk for …
Vertex cystic fibrosis drugs become available in Scotland after NHS rejection
September 12, 2019Sales and Marketing SMC, Vertex, cystic fibrosis
Two potentially life-changing cystic fibrosis drugs are to become available for a potential pool of 400 patients in Scotland just …
Read the September edition of Pharmafocus online now!
September 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma
The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …
UK cancer survival lagging behind other nations
September 12, 2019Research and Development Cancer, british nhs
Cancer survival in the UK is falling behind other high-income nations, despite seeing an overall improvement in survival rates, according …
Novartis’ Mayzent delays time wheelchair dependence by 4 years in secondary progressive multiple sclerosis
September 12, 2019Research and Development ECTRIMS 2019, Mayzent, Novartis, multiple sclerosis, pharma
Novartis has taken the opportunity at the 2019 Congress of The European Committee for Treatment and Research in Multiple Sclerosis …
Former Ergomed CEO appointed as Midatech’s Chief Financial Officer
September 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ergomed, midatech
Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect. He will be …
£200m largest ever genetics project launched to combat deadly diseases
September 11, 2019Research and Development
In a huge step forward for public health and the UK’s global leadership in genomics, a £200 million project has …
Decade-long data support Biogen’s Tecfidera in relapsing multiple sclerosis
September 11, 2019Research and Development Biogen, multiple sclerosis, pharma, tecfidera
Biogen has revealed new long-term data for Tecfidera (dimethyl fumarate), reinforcing the benefits of the therapy over a decade-long period …
New aggressive strain of Strep A spreading in UK
September 11, 2019Research and Development Strep A
A new strain of Streptococcus pyogenes called M1UK that is nine times more aggressive is spreading in the UK as …
BMS unveils strong five-year efficacy data for Opdivo in lung cancer
September 11, 2019Research and Development Bristol-Myers Squibb, Cancer, immunotherapy, lung cancer, pharma
Bristol-Myers Squibb has unveiled pooled five-year efficacy and safety results for its blockbuster immunotherapy Opdivo (nivolumab) drawn from two Phase …
GlaxoSmithKline acquires Sitari Pharmaceuticals after progress in coeliac disease
September 11, 2019Research and Development, Sales and Marketing Avalon Ventures, GSK, coeliac disease
Avalon Ventures has announced that it has entered into a definitive agreement with GSK for the acquisition of Sitari Pharmaceuticals …
Tony Coles appointed to Pfizer Spinout Cerevel as CEO
September 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerevel, Pfizer, pharma
Cerevel Therapeutics, a pharmaceutical company dedicated to treating neurological diseases, has appointed renowned biotechnology leader Tony Coles as Chief Executive …
Ayala hires AbbVie’s Gary Gordon as new CMO
September 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Ayala
AbbVie’s former Vice President of Oncology has moved to Ayala Pharmaceuticals to work as its new Chief Medical Officer (CMO). …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
